Immediate Impact
61 standout
Citing Papers
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients
2024 Standout
Cancer statistics, 2024
2024 Standout
Works of Terrence P. Cescon being referenced
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
2020
Prostate Cancer Risk Assessment Program: A 10-Year Update of Cancer Detection
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Terrence P. Cescon | 169 | 73 | 79 | 111 | 18 | 317 | |
| Martin J. Bury | 196 | 63 | 82 | 31 | 23 | 308 | |
| Isabelle Himsl | 101 | 38 | 75 | 50 | 14 | 353 | |
| Ashley Crook | 96 | 30 | 87 | 82 | 26 | 347 | |
| Andreas Nearchou | 200 | 45 | 97 | 83 | 14 | 369 | |
| R.A.E.M. Tollenaar | 161 | 58 | 56 | 55 | 22 | 337 | |
| Shicheng Weng | 123 | 79 | 89 | 27 | 17 | 349 | |
| Mike van Beek | 135 | 40 | 68 | 84 | 15 | 329 | |
| Edgard Nassif | 101 | 83 | 57 | 75 | 18 | 331 | |
| Michael Bernhard | 94 | 41 | 27 | 30 | 21 | 349 | |
| Norio Shiraki | 96 | 107 | 28 | 48 | 18 | 328 |
All Works
Loading papers...